Cargando…

Host predisposition by endogenous Transforming Growth Factor-β1 overexpression promotes pulmonary fibrosis following bleomycin injury

BACKGROUND: Idiopathic Pulmonary Fibrosis (IPF) is a progressive diffuse disease involving the lung parenchyma. Despite recent advances, the molecular mechanisms of the initiation and progression of this disease remain elusive. Previous studies have demonstrated TGFβ1 as a key effector cytokine in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Haider, Yussef, Malizia, Andrea P, Keating, Dominic T, Birch, Mary, Tomlinson, Annette, Martin, Gail, Ferguson, Mark WJ, Doran, Peter P, Egan, Jim J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169220/
https://www.ncbi.nlm.nih.gov/pubmed/17883846
http://dx.doi.org/10.1186/1476-9255-4-18
_version_ 1782144850695553024
author Haider, Yussef
Malizia, Andrea P
Keating, Dominic T
Birch, Mary
Tomlinson, Annette
Martin, Gail
Ferguson, Mark WJ
Doran, Peter P
Egan, Jim J
author_facet Haider, Yussef
Malizia, Andrea P
Keating, Dominic T
Birch, Mary
Tomlinson, Annette
Martin, Gail
Ferguson, Mark WJ
Doran, Peter P
Egan, Jim J
author_sort Haider, Yussef
collection PubMed
description BACKGROUND: Idiopathic Pulmonary Fibrosis (IPF) is a progressive diffuse disease involving the lung parenchyma. Despite recent advances, the molecular mechanisms of the initiation and progression of this disease remain elusive. Previous studies have demonstrated TGFβ1 as a key effector cytokine in the development of lung fibrosis. METHODS: In this study we have used a transgenic mouse based strategy to identify the effect of overexpression of this key effector mediator on the development of pulmonary fibrosis in response to exogenous injury. We bred two lines (line 25 and 18) of transgenic mice (Tr+) that overexpressed active TGFβ1. Three-month old transgenic and wild type mice were subsequently wounded with intraperitoneal bleomycin. Mice were sacrificed at 6 weeks post-bleomycin and their lungs analysed histologically and biochemically. RESULTS: The severity of lung fibrosis was significantly greater in the Tr+ mice compared to the wild type mice. Using an oligonucleotide microarray based strategy we identified discrete patterns of gene expression contributing to TGFβ1 associated pulmonary fibrosis. CONCLUSION: This data emphasises the importance of a host predisposition in the form of endogenous TGFβ1, in the development of pulmonary fibrosis in response to an exogenous injury.
format Text
id pubmed-2169220
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-21692202007-12-29 Host predisposition by endogenous Transforming Growth Factor-β1 overexpression promotes pulmonary fibrosis following bleomycin injury Haider, Yussef Malizia, Andrea P Keating, Dominic T Birch, Mary Tomlinson, Annette Martin, Gail Ferguson, Mark WJ Doran, Peter P Egan, Jim J J Inflamm (Lond) Research BACKGROUND: Idiopathic Pulmonary Fibrosis (IPF) is a progressive diffuse disease involving the lung parenchyma. Despite recent advances, the molecular mechanisms of the initiation and progression of this disease remain elusive. Previous studies have demonstrated TGFβ1 as a key effector cytokine in the development of lung fibrosis. METHODS: In this study we have used a transgenic mouse based strategy to identify the effect of overexpression of this key effector mediator on the development of pulmonary fibrosis in response to exogenous injury. We bred two lines (line 25 and 18) of transgenic mice (Tr+) that overexpressed active TGFβ1. Three-month old transgenic and wild type mice were subsequently wounded with intraperitoneal bleomycin. Mice were sacrificed at 6 weeks post-bleomycin and their lungs analysed histologically and biochemically. RESULTS: The severity of lung fibrosis was significantly greater in the Tr+ mice compared to the wild type mice. Using an oligonucleotide microarray based strategy we identified discrete patterns of gene expression contributing to TGFβ1 associated pulmonary fibrosis. CONCLUSION: This data emphasises the importance of a host predisposition in the form of endogenous TGFβ1, in the development of pulmonary fibrosis in response to an exogenous injury. BioMed Central 2007-09-20 /pmc/articles/PMC2169220/ /pubmed/17883846 http://dx.doi.org/10.1186/1476-9255-4-18 Text en Copyright © 2007 Haider et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Haider, Yussef
Malizia, Andrea P
Keating, Dominic T
Birch, Mary
Tomlinson, Annette
Martin, Gail
Ferguson, Mark WJ
Doran, Peter P
Egan, Jim J
Host predisposition by endogenous Transforming Growth Factor-β1 overexpression promotes pulmonary fibrosis following bleomycin injury
title Host predisposition by endogenous Transforming Growth Factor-β1 overexpression promotes pulmonary fibrosis following bleomycin injury
title_full Host predisposition by endogenous Transforming Growth Factor-β1 overexpression promotes pulmonary fibrosis following bleomycin injury
title_fullStr Host predisposition by endogenous Transforming Growth Factor-β1 overexpression promotes pulmonary fibrosis following bleomycin injury
title_full_unstemmed Host predisposition by endogenous Transforming Growth Factor-β1 overexpression promotes pulmonary fibrosis following bleomycin injury
title_short Host predisposition by endogenous Transforming Growth Factor-β1 overexpression promotes pulmonary fibrosis following bleomycin injury
title_sort host predisposition by endogenous transforming growth factor-β1 overexpression promotes pulmonary fibrosis following bleomycin injury
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169220/
https://www.ncbi.nlm.nih.gov/pubmed/17883846
http://dx.doi.org/10.1186/1476-9255-4-18
work_keys_str_mv AT haideryussef hostpredispositionbyendogenoustransforminggrowthfactorb1overexpressionpromotespulmonaryfibrosisfollowingbleomycininjury
AT maliziaandreap hostpredispositionbyendogenoustransforminggrowthfactorb1overexpressionpromotespulmonaryfibrosisfollowingbleomycininjury
AT keatingdominict hostpredispositionbyendogenoustransforminggrowthfactorb1overexpressionpromotespulmonaryfibrosisfollowingbleomycininjury
AT birchmary hostpredispositionbyendogenoustransforminggrowthfactorb1overexpressionpromotespulmonaryfibrosisfollowingbleomycininjury
AT tomlinsonannette hostpredispositionbyendogenoustransforminggrowthfactorb1overexpressionpromotespulmonaryfibrosisfollowingbleomycininjury
AT martingail hostpredispositionbyendogenoustransforminggrowthfactorb1overexpressionpromotespulmonaryfibrosisfollowingbleomycininjury
AT fergusonmarkwj hostpredispositionbyendogenoustransforminggrowthfactorb1overexpressionpromotespulmonaryfibrosisfollowingbleomycininjury
AT doranpeterp hostpredispositionbyendogenoustransforminggrowthfactorb1overexpressionpromotespulmonaryfibrosisfollowingbleomycininjury
AT eganjimj hostpredispositionbyendogenoustransforminggrowthfactorb1overexpressionpromotespulmonaryfibrosisfollowingbleomycininjury